Post Marketing Information PEM 19/06/2024 ULTOMIRIS® (ravulizumab): PHYSICIAN’S GUIDE PMG 19/06/2024 ULTOMIRIS® (ravulizumab): Patient/Parent/Legal Guardian Guide PAC 19/06/2024 Patient Safety Information Card: ULTOMIRIS® (ravulizumab)
INTRAVENOUS Select a brand starting with the letter: U ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML [SIN17026P]